Lupin receives final approval for Carbidopa Tablets

Capital Market 

From USFDA

has received final approval for its Carbidopa Tablets, 25 mg from the USFDA to market generic version of Aton Pharma Inc.'s Lodosyn Tablets, 25 mg.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, October 24 2017. 18:30 IST